• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity.丙酮酸脱氢酶激酶-4结构揭示了一种促进强大无核心基础活性的亚稳态开放构象。
J Biol Chem. 2008 Sep 12;283(37):25305-25315. doi: 10.1074/jbc.M802249200. Epub 2008 Jul 24.
2
Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4.
Acta Crystallogr D Biol Crystallogr. 2011 Sep;67(Pt 9):763-73. doi: 10.1107/S090744491102405X. Epub 2011 Aug 9.
3
Pivotal role of the C-terminal DW-motif in mediating inhibition of pyruvate dehydrogenase kinase 2 by dichloroacetate.C 末端 DW 基序在二氯乙酸介导的丙酮酸脱氢酶激酶 2 抑制中起关键作用。
J Biol Chem. 2009 Dec 4;284(49):34458-67. doi: 10.1074/jbc.M109.065557. Epub 2009 Oct 15.
4
Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex.与人类丙酮酸脱氢酶复合体的硫辛酰结构域2结合的丙酮酸脱氢酶激酶3的晶体结构
EMBO J. 2005 May 18;24(10):1763-74. doi: 10.1038/sj.emboj.7600663. Epub 2005 Apr 28.
5
The carboxy-terminal tail of pyruvate dehydrogenase kinase 2 is required for the kinase activity.丙酮酸脱氢酶激酶2的羧基末端尾部是激酶活性所必需的。
Biochemistry. 2005 Oct 18;44(41):13573-82. doi: 10.1021/bi0505868.
6
Structural determinants for cross-talk between pyruvate dehydrogenase kinase 3 and lipoyl domain 2 of the human pyruvate dehydrogenase complex.人丙酮酸脱氢酶复合体中丙酮酸脱氢酶激酶3与硫辛酰结构域2之间相互作用的结构决定因素。
J Biol Chem. 2006 Sep 15;281(37):27197-204. doi: 10.1074/jbc.M604339200. Epub 2006 Jul 18.
7
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.AZD7545、二氯乙酸和鬼笔环肽抑制丙酮酸脱氢酶激酶同工型的不同结构机制。
Structure. 2007 Aug;15(8):992-1004. doi: 10.1016/j.str.2007.07.001. Epub 2007 Aug 2.
8
Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms.丙酮酸脱氢酶激酶和磷酸酶同工型的独特调节特性。
Prog Nucleic Acid Res Mol Biol. 2001;70:33-75. doi: 10.1016/s0079-6603(01)70013-x.
9
Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands.基于包含生理和合成配体的人丙酮酸脱氢酶激酶2晶体结构的N端结构域的调控作用。
Biochemistry. 2006 Jan 17;45(2):402-15. doi: 10.1021/bi051402s.
10
Structural basis for the inhibition of PDK2 by novel ATP- and lipoyl-binding site targeting compounds.新型靶向 ATP 和硫辛酰结合位点的 PDK2 抑制剂的结构基础。
Biochem Biophys Res Commun. 2020 Jun 30;527(3):778-784. doi: 10.1016/j.bbrc.2020.04.102. Epub 2020 May 20.

引用本文的文献

1
The impact of ER on mitochondrial integrity mediated by PDK4.内质网(ER)通过丙酮酸脱氢酶激酶4(PDK4)介导对线粒体完整性的影响。
Cell Death Dis. 2025 Jul 29;16(1):573. doi: 10.1038/s41419-025-07743-5.
2
Ablation of the Evolutionarily Acquired Functions of the Gene Increases Metabolic Capacity and Reduces Obesity.消除该基因进化获得的功能可提高代谢能力并减轻肥胖。
Life (Basel). 2025 Jul 14;15(7):1103. doi: 10.3390/life15071103.
3
Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation.软骨细胞脂肪酸氧化通过SOX9降解和表观遗传调控驱动骨关节炎。
Nat Commun. 2025 May 27;16(1):4892. doi: 10.1038/s41467-025-60037-4.
4
Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies.3型糖尿病与脑神经元的代谢重编程:病因与治疗策略
Mol Med. 2025 Feb 18;31(1):61. doi: 10.1186/s10020-025-01101-z.
5
Mitochondrial Alpha-Keto Acid Dehydrogenase Complexes: Recent Developments on Structure and Function in Health and Disease.线粒体 α-酮酸脱氢酶复合物:在健康和疾病中的结构和功能的最新进展。
Subcell Biochem. 2024;104:295-381. doi: 10.1007/978-3-031-58843-3_13.
6
Phenylbutyrate and Dichloroacetate Enhance the Liquid-Stored Boar Sperm Quality via PDK1 and PDK3.苯丁酸钠和二氯醋酸盐通过 PDK1 和 PDK3 增强液态贮存公猪精子质量。
Int J Mol Sci. 2023 Dec 4;24(23):17091. doi: 10.3390/ijms242317091.
7
Acetate controls endothelial-to-mesenchymal transition.醋酸盐控制内皮细胞向间充质转化。
Cell Metab. 2023 Jul 11;35(7):1163-1178.e10. doi: 10.1016/j.cmet.2023.05.010. Epub 2023 Jun 15.
8
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma.海洋天然产物的结构修饰激发了具有抗肿瘤活性的新型 3-氨基-1,2,4-三嗪 PDK 抑制剂文库在胰腺导管腺癌中的应用。
Mar Drugs. 2023 May 4;21(5):288. doi: 10.3390/md21050288.
9
Molecular interaction studies on ellagic acid for its anticancer potential targeting pyruvate dehydrogenase kinase 3.针对鞣花酸靶向丙酮酸脱氢酶激酶3的抗癌潜力的分子相互作用研究。
RSC Adv. 2019 Jul 29;9(40):23302-23315. doi: 10.1039/c9ra02864a. eCollection 2019 Jul 23.
10
Mitochondria in Myelinating Oligodendrocytes: Slow and Out of Breath?髓鞘形成少突胶质细胞中的线粒体:行动迟缓且气喘吁吁?
Metabolites. 2021 Jun 5;11(6):359. doi: 10.3390/metabo11060359.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice.丙酮酸脱氢酶激酶4缺乏可降低饮食诱导的肥胖小鼠的血糖并改善其糖耐量。
Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E46-54. doi: 10.1152/ajpendo.00536.2007. Epub 2008 Apr 22.
3
Structural and functional insights into the molecular mechanisms responsible for the regulation of pyruvate dehydrogenase kinase 2.对负责丙酮酸脱氢酶激酶2调控的分子机制的结构和功能见解。
J Biol Chem. 2008 Jun 6;283(23):15789-98. doi: 10.1074/jbc.M800311200. Epub 2008 Apr 3.
4
Specific ion influences on self-association of pyruvate dehydrogenase kinase isoform 2 (PDHK2), binding of PDHK2 to the L2 lipoyl domain, and effects of the lipoyl group-binding site inhibitor, Nov3r.特定离子对丙酮酸脱氢酶激酶同工型2(PDHK2)自缔合的影响、PDHK2与L2硫辛酰结构域的结合以及硫辛酰基团结合位点抑制剂Nov3r的作用。
Biochemistry. 2008 Feb 26;47(8):2312-24. doi: 10.1021/bi7014772. Epub 2008 Jan 26.
5
Critical role of specific ions for ligand-induced changes regulating pyruvate dehydrogenase kinase isoform 2.特定离子在配体诱导的调节丙酮酸脱氢酶激酶同工型2变化中的关键作用。
Biochemistry. 2008 Feb 26;47(8):2298-311. doi: 10.1021/bi701475f. Epub 2008 Jan 26.
6
Structures of the human pyruvate dehydrogenase complex cores: a highly conserved catalytic center with flexible N-terminal domains.人类丙酮酸脱氢酶复合体核心结构:具有灵活N端结构域的高度保守催化中心。
Structure. 2008 Jan;16(1):104-14. doi: 10.1016/j.str.2007.10.024.
7
Age-dependent kinetics and metabolism of dichloroacetate: possible relevance to toxicity.二氯乙酸的年龄依赖性动力学和代谢:与毒性的可能关联。
J Pharmacol Exp Ther. 2008 Mar;324(3):1163-71. doi: 10.1124/jpet.107.134593. Epub 2007 Dec 20.
8
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.AZD7545、二氯乙酸和鬼笔环肽抑制丙酮酸脱氢酶激酶同工型的不同结构机制。
Structure. 2007 Aug;15(8):992-1004. doi: 10.1016/j.str.2007.07.001. Epub 2007 Aug 2.
9
Recognition of the inner lipoyl-bearing domain of dihydrolipoyl transacetylase and of the blood glucose-lowering compound AZD7545 by pyruvate dehydrogenase kinase 2.丙酮酸脱氢酶激酶2对二氢硫辛酰转乙酰基酶的内部含硫辛酰结构域和降血糖化合物AZD7545的识别。
Biochemistry. 2007 Jul 24;46(29):8592-602. doi: 10.1021/bi700650k. Epub 2007 Jun 30.
10
The two active sites in human branched-chain alpha-keto acid dehydrogenase operate independently without an obligatory alternating-site mechanism.人类支链α-酮酸脱氢酶中的两个活性位点独立运作,不存在强制性的交替位点机制。
J Biol Chem. 2007 Apr 20;282(16):11904-13. doi: 10.1074/jbc.M610843200. Epub 2007 Feb 27.

丙酮酸脱氢酶激酶-4结构揭示了一种促进强大无核心基础活性的亚稳态开放构象。

Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity.

作者信息

Wynn R Max, Kato Masato, Chuang Jacinta L, Tso Shih-Chia, Li Jun, Chuang David T

机构信息

Department of Biochemistry, Dallas, Texas 75390-9038; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9038.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9038.

出版信息

J Biol Chem. 2008 Sep 12;283(37):25305-25315. doi: 10.1074/jbc.M802249200. Epub 2008 Jul 24.

DOI:10.1074/jbc.M802249200
PMID:18658136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2533096/
Abstract

Human pyruvate dehydrogenase complex (PDC) is down-regulated by pyruvate dehydrogenase kinase (PDK) isoforms 1-4. PDK4 is overexpressed in skeletal muscle in type 2 diabetes, resulting in impaired glucose utilization. Here we show that human PDK4 has robust core-free basal activity, which is considerably higher than activity levels of other PDK isoforms stimulated by the PDC core. PDK4 binds the L3 lipoyl domain, but its activity is not significantly stimulated by any individual lipoyl domains or the core of PDC. The 2.0-A crystal structures of the PDK4 dimer with bound ADP reveal an open conformation with a wider active-site cleft, compared with that in the closed conformation epitomized by the PDK2-ADP structure. The open conformation in PDK4 shows partially ordered C-terminal cross-tails, in which the conserved DW (Asp(394)-Trp(395)) motif from one subunit anchors to the N-terminal domain of the other subunit. The open conformation fosters a reduced binding affinity for ADP, facilitating the efficient removal of product inhibition by this nucleotide. Alteration or deletion of the DW-motif disrupts the C-terminal cross-tail anchor, resulting in the closed conformation and the nearly complete inactivation of PDK4. Fluorescence quenching and enzyme activity data suggest that compounds AZD7545 and dichloroacetate lock PDK4 in the open and the closed conformational states, respectively. We propose that PDK4 with bound ADP exists in equilibrium between the open and the closed conformations. The favored metastable open conformation is responsible for the robust basal activity of PDK4 in the absence of the PDC core.

摘要

人丙酮酸脱氢酶复合体(PDC)受丙酮酸脱氢酶激酶(PDK)亚型1 - 4的下调作用影响。在2型糖尿病患者的骨骼肌中,PDK4过度表达,导致葡萄糖利用受损。在此我们表明,人PDK4具有强大的无核心基础活性,这一活性显著高于由PDC核心激活的其他PDK亚型的活性水平。PDK4与L3硫辛酰结构域结合,但其活性不受任何单个硫辛酰结构域或PDC核心的显著刺激。结合ADP的PDK4二聚体的2.0埃晶体结构显示,与以PDK2 - ADP结构为代表的封闭构象相比,其为具有更宽活性位点裂缝的开放构象。PDK4中的开放构象显示出部分有序的C末端交叉尾,其中一个亚基中保守的DW(Asp(394)-Trp(395))基序锚定到另一个亚基的N末端结构域。开放构象导致对ADP的结合亲和力降低,有利于有效消除该核苷酸对产物的抑制作用。DW基序的改变或缺失会破坏C末端交叉尾的锚定,导致封闭构象以及PDK4几乎完全失活。荧光猝灭和酶活性数据表明,化合物AZD7545和二氯乙酸盐分别将PDK4锁定在开放和封闭构象状态。我们提出,结合ADP的PDK4在开放和封闭构象之间存在平衡。这种有利的亚稳态开放构象是PDK4在没有PDC核心时具有强大基础活性的原因。